What are the ongoing clinical trials investigating novel EGFR-targeted strategies?

A mutation in the EGFR gene can be found in some people who have been diagnosed with non-small cell lung cancer (NSCLC). NSCLC with an EGFR mutation is known as ... Aug 10, 2021 ... Asia has the highest prevalence of epidermal growth factor receptor (EGFR) mutations in patients with non-small cell lung cancer (NSCLC). Aug 16, 2024 ... eGFR measures how well your kidneys are functioning. It measures your kidneys' ability to filter waste and toxic components from the blood. Summary. EGFR mutation in lung cancer occurs due to a mutation in a person's EGFR protein. There are various subtypes of EGFR mutations. The type of EGFR ... eGFR is a measure of how well your kidneys are working. Measuring serum creatinine along with an estimated glomerular filtration rate (eGFR) is recommended as ... Alongside your eGFR, urine tests can help give a more accurate picture of how well your kidneys are working. Other tests. Sometimes other tests are also used to ... Sep 27, 2024 ... Drugs Targeting EGFR: Lung cancer questions? We can help! Connect with a member of our professional support team today. Mar 11, 2025 ... What is the eGFR blood test? The eGFR blood test is a measure of how well the kidneys are functioning to remove waste products, such as ... Jan 22, 2025 ... EGFR-positive lung cancer represents about 10-15% of lung cancers in the United States and most often appears in the adenocarcinoma subtype of non-small cell ... Dec 4, 2019 ... A phase 3 trial compared first-line osimertinib with other EGFR-TKIs in patients with EGFR mutation–positive advanced non–small-cell lung cancer (NSCLC).